| _version_ | 1866901268534919168 |
|---|---|
| author | Tripdatabase |
| author_facet | Tripdatabase |
| contents | Low-dose naltrexone shows potential in treating inflammatory and autoimmune skin conditions like Hailey-Hailey disease, but further research is necessary to solidify its efficacy and safety profile. |
| format | Recurso digital |
| id | zenodo_https___doi_org_10_5281_zenodo_17719289 |
| institution | Zenodo |
| language | |
| publishDate | 2025 |
| publisher | Zenodo |
| record_format | zenodo |
| spellingShingle | What is the evidence for the use of low-dose naltrexone in treating inflammatory or autoimmune skin conditions? Tripdatabase evidence use low dose naltrexone treating inflammatory autoimmune skin conditions Low-dose naltrexone shows potential in treating inflammatory and autoimmune skin conditions like Hailey-Hailey disease, but further research is necessary to solidify its efficacy and safety profile. |
| title | What is the evidence for the use of low-dose naltrexone in treating inflammatory or autoimmune skin conditions? |
| topic | evidence use low dose naltrexone treating inflammatory autoimmune skin conditions |
| url | https://doi.org/10.5281/zenodo.17719289 |